C07C209/90

Method for manufacturing diisocyanate and optical lens

Provided is a method for manufacturing diisocyanate and an optical lens in which, during the manufacture of diisocyanate from diamine via diamine hydrochloride, use is made of an aqueous hydrochloric acid solution and an organic solvent instead of hydrogen chloride gas and solid-phase triphosgen instead of phosgen gas while reaction conditions are controlled, whereby the diisocyanate of high quality can be manufactured at excellent yield, with the causation of less environmental problems.

Method for manufacturing diisocyanate and optical lens

Provided is a method for manufacturing diisocyanate and an optical lens in which, during the manufacture of diisocyanate from diamine via diamine hydrochloride, use is made of an aqueous hydrochloric acid solution and an organic solvent instead of hydrogen chloride gas and solid-phase triphosgen instead of phosgen gas while reaction conditions are controlled, whereby the diisocyanate of high quality can be manufactured at excellent yield, with the causation of less environmental problems.

Branched-chain fatty acids as liquid cation exchangers

The present invention relates to a method for removing an organic compound from an aqueous solution, comprising the steps of providing the aqueous solution which contains the organic compound, and a hydrophobic organic solution, where the latter comprises a liquid hydrophobic cation exchanger, contacting the aqueous solution and the hydrophobic organic solution, and separating off the hydrophobic organic solution from the aqueous solution, wherein the liquid hydrophobic cation exchanger is a saturated alkanoic acid having at least one alkyl substituent, where the organic compound is an organic compound having at least one positive charge and a neutral or positive total charge.

Branched-chain fatty acids as liquid cation exchangers

The present invention relates to a method for removing an organic compound from an aqueous solution, comprising the steps of providing the aqueous solution which contains the organic compound, and a hydrophobic organic solution, where the latter comprises a liquid hydrophobic cation exchanger, contacting the aqueous solution and the hydrophobic organic solution, and separating off the hydrophobic organic solution from the aqueous solution, wherein the liquid hydrophobic cation exchanger is a saturated alkanoic acid having at least one alkyl substituent, where the organic compound is an organic compound having at least one positive charge and a neutral or positive total charge.

COMPLEX OF LAMELLAR INORGANIC COMPOUND AND ORGANIC COMPOUND AND METHOD OF PRODUCING THEREOF, DELAMINATED LAMELLAR INORGANIC COMPOUND AND METHOD OF PRODUCING THEREOF, INSULATING RESIN COMPOSITION, RESIN SHEET, INSULATOR, RESIN SHEET CURED PRODUCT, AND HEAT DISSIPATING MEMBER

A method of producing a complex of a lamellar inorganic compound and an organic compound includes: heat-treating a particular non-swelling lamellar inorganic compound within a pyrolysis temperature range of the non-swelling lamellar inorganic compound; and intercalating an organic compound into the non-swelling lamellar inorganic compound in a dispersion liquid in which the heat-treated non-swelling lamellar inorganic compound is dispersed in a medium, thereby inserting the organic compound into an interlamellar space of the non-swelling lamellar inorganic compound.

COMPLEX OF LAMELLAR INORGANIC COMPOUND AND ORGANIC COMPOUND AND METHOD OF PRODUCING THEREOF, DELAMINATED LAMELLAR INORGANIC COMPOUND AND METHOD OF PRODUCING THEREOF, INSULATING RESIN COMPOSITION, RESIN SHEET, INSULATOR, RESIN SHEET CURED PRODUCT, AND HEAT DISSIPATING MEMBER

A method of producing a complex of a lamellar inorganic compound and an organic compound includes: heat-treating a particular non-swelling lamellar inorganic compound within a pyrolysis temperature range of the non-swelling lamellar inorganic compound; and intercalating an organic compound into the non-swelling lamellar inorganic compound in a dispersion liquid in which the heat-treated non-swelling lamellar inorganic compound is dispersed in a medium, thereby inserting the organic compound into an interlamellar space of the non-swelling lamellar inorganic compound.

Method for preserving 1,5-pentanediamine or salt thereof, method for preventing discoloration of 1,5-pentanediamine or salt thereof, and 1,5-pentanediamine or salt thereof in container

Means of preserving 1,5-pentanediamine or a salt thereof without deterioration is provided. 1,5-pentanediamine or a salt thereof is preserved by adjusting any of a water content of 1,5-pentanediamine or a salt thereof purified through a distillation process, a temperature condition, and a material that comes into contact with 1,5-pentanediamine or a salt thereof.

Method for preserving 1,5-pentanediamine or salt thereof, method for preventing discoloration of 1,5-pentanediamine or salt thereof, and 1,5-pentanediamine or salt thereof in container

Means of preserving 1,5-pentanediamine or a salt thereof without deterioration is provided. 1,5-pentanediamine or a salt thereof is preserved by adjusting any of a water content of 1,5-pentanediamine or a salt thereof purified through a distillation process, a temperature condition, and a material that comes into contact with 1,5-pentanediamine or a salt thereof.

Method for preserving 1,5-pentanediamine or salt thereof, method for preventing discoloration of 1,5-pentanediamine or salt thereof, and 1,5-pentanediamine or salt thereof in container

Means of preserving 1,5-pentanediamine or a salt thereof without deterioration is provided. 1,5-pentanediamine or a salt thereof is preserved by adjusting any of a water content of 1,5-pentanediamine or a salt thereof purified through a distillation process, a temperature condition, and a material that comes into contact with 1,5-pentanediamine or a salt thereof.

Trientine tetrahydrochloride and a method of preparation and a pharmaceutical composition thereof

A method of preparation of trientine tetrahydrochloride crystals in which an anti-solvent at a feeding temperature is added into a trientine tetrahydrochloride solution and stirred for crystallization wherein the feeding temperature ranges from 50 C. to 75 C. and the anti-solvent is an alcohol solvent. A novel trientine tetrahydrochloride featuring XRPD peaks detected at 21.9, 24.8, 25.2, 28.0 and 35.60.1 2 for stable storage of a pharmaceutical composition manufactured with the trientine tetrahydrochloride.